ALB and metabolic dysfunction-associated steatotic liver disease: The NAFLD fibrosis score (http://nafldscore.com/) is a promising bedside tool for identifying NAFLD patients who are at high risk for advanced fibrosis, and it employs six easily available variables (age, hyperglycemia, body mass index, platelet count, albumin, and AST/ALT ratio).58 In a recent meta-analysis of 13 published studies, the NAFLD fibrosis score had a pooled area under the curve of a receiver operating characteristic (AUROC) of 0.85 for predicting advanced fibrosis (stage 3 or 4).